Conditional Risk Factors for Atherosclerosis

Kullo, Iftikhar J.; Ballantyne, Christie M.
February 2005
Mayo Clinic Proceedings;Feb2005, Vol. 80 Issue 2, p219
Academic Journal
Although most patients who experience a coronary heart disease (CHD) event have one or more of the conventional risk factors for atherosclerosis, so do many people who have not yet experienced such an event. Therefore, predictive models based on conventional risk factors have a lower than desired accuracy, providing a stimulus to search for new tools to refine CHD risk prediction. In particular, there is intense interest in evaluating circulating blomarkers related to the atheroscierotic process that might add to our ability to better predict CHD risk. One such group of biomarkers was termed conditional risk factors in an American Heart Association/American College of Cardiology statement in 1999. The conditional risk factors include homocysteine, fibrinogen, lipoprotein(a), low-density lipoprotein particle size, and C-reactive protein. This review updates the conditional risk factors. The main focus is on the potential utility of these risk factors, which are currently avaliable to clinicians, in the prediction of CHD risk in asymptomatic persons. The putative mechanisms of risk, available assays, evidence for association with CHD, and the clinical implications thereof are discussed for each of the risk factors.


Related Articles

  • Inflammatory biomarkers and the prediction of coronary events among people at intermediate risk: the EPIC-Norfolk prospective population study. Rana, J. S.; Cote, M.; Després, J.-P.; Sandhu, M. S.; Talmud, P. J.; Ninio, E.; Wareham, N. J.; Kastelein, J. J. P.; Zwinderman, A. H.; Khaw, K.-T.; Boekholdt, S. M. // Heart;Oct2009, Vol. 92 Issue 20, p1682 

    Objective: To evaluate the role of the inflammatory biomarkers C-reactive protein (CRP), myeloperoxidase, paraoxonase, secretory phospholipase A2 group IIA (sPLA2), lipoprotein-associated phospholipase A2, fibrinogen, macrophage chemoattractant protein-1 and adiponectin, in predicting the risk...

  • Genotypes associated with CRP elevations.  // Infectious Disease Alert;Jan2009 Primary Care, p1 

    The article discusses a study on whether the observed relationship between elevated C-reactive protein (CRP) levels and adverse cardiovascular (CV) outcomes is causal. It reports that elevated CRP levels were associated with an increased risk of ischemic heart disease but individuals evaluated...

  • Serum hsCRP: A Novel Marker for Prediction of Cerebrovascular Accidents (Stroke). PATGIRI, DIBYARATNA; SAIKIA PATHAK, MAUCHUMI; SHARMA, PRADEEP; KUTUM, TRIDIP; MATTACK, NIRMALI // Journal of Clinical & Diagnostic Research;Dec2014, Vol. 8 Issue 12, p8 

    Introduction and Objectives: Strokes are caused by disruption of the blood supply to the brain. This may result from either blockage or rupture of a blood vessel. Yearly 15 million people worldwide suffer a stroke. India ranks second worldwide in terms of deaths from stroke. The incidence of...

  • C reactive protein and the risk of cardiovascular disease: Are dearly linked but a causal association is unlikely. Keavney, Bernard // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;2/19/2011, Vol. 342 Issue 7794, p393 

    The author discusses the linked study between the C reactive protein (CRP) and coronary heart disease. He explains that the C Reactive Protein Coronary Heart Disease Genetics Collaboration is a combination of genetics and meta-analysis designed to assess whether coronary heart disease is caused...

  • Inflammation in ischaemic heart disease. Maseri, Attilio; Biasucci, Luigi M.; Liuzzo, Giovanna // BMJ: British Medical Journal (International Edition);4/27/96, Vol. 312 Issue 7038, p1049 

    Editorial. Comments on the results of the study conducted by Mendall et al. from London, England showing the relation between C reactive protein concentrations and the risk factors for ischemic heart disease. Effects of the increase in C reactive protein concentrations; Useful information...

  • Effect of Exercise at Different Times of Day on the Inflammatory markers of cardiovascular disease Risk in Obese Men. Peeri, Maghsoud; Assarzadeh, Mohsen; Azarbayjani, M.Ali; Agaalinejad, Hamid // Annals of Biological Research;2011, Vol. 2 Issue 5, p213 

    The aim of the present research was to determine the effect of exercise at different times of day on the inflammatory markers which make the risk of coronary heart diseases in obese men. 40 non-athletes, obese men (age mean 22.25±2.5 and weight mean 89.74±6.07) were randomly allocated to...

  • Biomarkers for coronary heart disease: predictive value or background noise? Mitka, Mike // JAMA: Journal of the American Medical Association;12/15/2004, Vol. 292 Issue 23, p2824 

    Looks at biomarkers for disease and how they may eventually aid in the diagnosis of illness. Attention on biomarker C-reactive protein which has been shown as a predictor of risk of myocardial infarction, stroke, sudden heart attack and peripheral arterial disease; Recommendations for when to...

  • The Correlation between High-Sensitivity C-Reactive Protein (hsCRP) Serum Levels and Severity of Coronary Atherosclerosis. Mohammad Assadpour Piranfar // International Cardiovascular Research Journal;Jan-Mar2014, Vol. 8 Issue 1, p6 

    Background: Considering the increasing incidence of coronary artery stenosis as well as its related complications, the importance of its etiology, and inconsistent reports, we aimed to determine the relationship between High-sensitivity C-reactive protein (hsCRP) serum levels and severity of...

  • Asymptomatic subjects with diabetes have a comparable risk of coronary artery disease to Nondiabetic subjects presenting chest pain: a 4-year community-based prospective study. Bo Kyung Koo; Yun Gi Kim; Kyong Soo Park; Min Kyong Moon // BMC Cardiovascular Disorders;2013, Vol. 13 Issue 1, p1 

    Background Although diabetes mellitus is an important risk factor of coronary artery disease (CAD), routine screening for CAD is not recommended for asymptomatic diabetic patients. We assessed the impact of chest pain on CAD risk according to the presence or absence of diabetes mellitus. Methods...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics